Breaking news: is silk road medical's $27.50 per share sale price a fair deal? johnson fistel, llp investigates deal terms

San diego, june 18, 2024 (globe newswire) -- johnson fistel, llp, a leading shareholder rights law firm, announced today that it has initiated an investigation into the board members of silk road medical, inc. (nasdaq: silk) concerning potential breaches of fiduciary duties related to the proposed sale of the company to boston scientific (nyse:bsx).
BSX Ratings Summary
BSX Quant Ranking